VANI

1.1404.59%
DD

Donald Dwyer

Chief Business Officer & Corporate Secretary

Mr. Donald Dwyer, also knowns as Don, MBA, was Consulting Chief Business Officer at Cortigent, Inc. until 2026. Mr. Dwyer serves as Chief Business Officer & Corporate Secretary at Vivani Medical, Inc. since 2022. Mr. Dwyer served as Chief Business Officer at Second Sight Medical Products, Inc. since September 2020. Mr. Dwyer is a science-based business leader with experience in the biopharmaceutical industry and a broad background in leadership across a wide range of technologies and disease areas. Mr. Dwyer has held director level positions in quality assurance/control and regulatory affairs at Rhone-Poulenc Rorer (now part of Sanofi), from 1986 to 1993 and Cephalon (now part of Teva Pharmaceuticals), from 1993 to 1995); and drug development, sales, commercial and business development at AstraZeneca, from 1995 to 2019. He also served as AstraZeneca observer on the Board of Directors for Phase Bio until a successful IPO, (2014 – 2018) and NPM (2015 – 2019). At AstraZeneca he was Executive Director Business Development and Early Asset (pre-Phase 3). He was also US commercial head for key brands including TOPROL-XL (heart failure, hypertension, angina); ATACAND (hypertension); ONGLYZA (diabetes); FORXIGA (diabetes); SEROQUEL (bipolar disorder) and ABRAXANE (cancer). Mr. Dwyer holds B.A from the University of Central Connecticut (Chemistry/Biology) and holds an MBA from the Temple University Fox School of Business.

公司职务